Harbor Capital Advisors Inc. Acquires 179,733 Shares of OrthoPediatrics Corp. $KIDS

Key Points

• Harbor Capital Advisors Inc. has increased its stake in OrthoPediatrics Corp. by 116.5%, owning a total of 333,959 shares valued at approximately $7.17 million as of the latest SEC disclosure.
• Analyst ratings for OrthoPediatrics reflect positive sentiment, with seven analysts giving a Buy rating and a consensus price target set at $34.14.
• Insider trading activity includes CFO Fred Hite purchasing 5,076 shares at an average price of $19.41 per share, increasing his holdings to a total value of approximately $4.14 million.

Harbor Capital Advisors Inc. raised its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 116.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 333,959 shares of the company's stock after acquiring an additional 179,733 shares during the period. Harbor Capital Advisors Inc. owned about 1.38% of OrthoPediatrics worth $7,173,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Northern Trust Corp boosted its stake in shares of OrthoPediatrics by 0.3% during the fourth quarter. Northern Trust Corp now owns 193,798 shares of the company's stock valued at $4,492,000 after purchasing an additional 644 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of OrthoPediatrics by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock valued at $246,000 after purchasing an additional 645 shares during the period. Invesco Ltd. boosted its stake in shares of OrthoPediatrics by 12.1% during the first quarter. Invesco Ltd. now owns 18,349 shares of the company's stock valued at $452,000 after purchasing an additional 1,986 shares during the period. American Century Companies Inc. boosted its stake in shares of OrthoPediatrics by 16.1% during the first quarter. American Century Companies Inc. now owns 30,658 shares of the company's stock valued at $755,000 after purchasing an additional 4,248 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of OrthoPediatrics by 46.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,148 shares of the company's stock valued at $348,000 after purchasing an additional 4,508 shares during the period. 69.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

KIDS has been the subject of a number of analyst reports. Wall Street Zen raised OrthoPediatrics from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. BTIG Research dropped their price target on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating for the company in a research note on Wednesday, August 6th. Citigroup reaffirmed a "market outperform" rating on shares of OrthoPediatrics in a research note on Friday, August 8th. Finally, JMP Securities set a $35.00 price target on OrthoPediatrics and gave the stock a "market outperform" rating in a research note on Friday, August 8th. Seven analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, OrthoPediatrics has an average rating of "Moderate Buy" and a consensus target price of $34.14.

Insider Activity

In other news, CFO Fred Hite purchased 5,076 shares of the business's stock in a transaction on Thursday, August 21st. The stock was acquired at an average cost of $19.41 per share, for a total transaction of $98,525.16. Following the purchase, the chief financial officer directly owned 213,065 shares in the company, valued at $4,135,591.65. This trade represents a 2.44% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 31.80% of the stock is currently owned by corporate insiders.

OrthoPediatrics Price Performance

NASDAQ KIDS opened at $19.56 on Tuesday. OrthoPediatrics Corp. has a one year low of $16.59 and a one year high of $32.93. The stock has a 50-day moving average of $20.86 and a 200 day moving average of $21.84. The company has a market capitalization of $490.37 million, a price-to-earnings ratio of -10.93 and a beta of 1.06. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.06. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The company had revenue of $61.08 million during the quarter, compared to the consensus estimate of $61.40 million. OrthoPediatrics has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.